In the present paper, it is attempted to empirically verify the impact of economic liberalization on the R&D behaviour of Indian pharmaceutical firms controlling for the effects of several firm specific characteristics including firm size. The results from the Tobit analysis for a sample of...

Cross-border and domestic merger and acquisitions are considered as fastest means of growth and survival too. This study provides evidence on the value creation by applying inorganic growth strategies based on a sample of Indian pharmaceutical companies. Relying on the key financial ratios,...

The paper examines the effectiveness of mergers as used by the corporate bodies as one of the strategic tools in improving post-merger financial performance. A comparative analysis of some selected Indian pharmaceutical companies' pre- and post-merger financial performance was conducted on the...

In the new economy, Intellectual Capital (IC) has been identified as one of the most important factors in driving economic growth. Rapid globalization characterized by advances in technology, research and development and increasing competition has been essentially driven by growth in IC....